KIMSKrishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences takes 5.82% stake for ₹15 crore

Agreement
Healthcare

Blacklitt Research29 October 20262 min read

A brick hospital building with a curved entrance canopy. — Photo by National Cancer Institute on Unsplash (Unsplash License). Illustrative image.

Krishna Institute of Medical Sciences (NSE: KIMS) has acquired 5.82% of Ushahkal Abhinav Specialty Hospital LLP in Sangli for ₹15 crore, paid in cash by way of primary infusion, it said in a filing on 29 Oct 2026. The target is a quaternary care facility with a current capacity of 316 beds and potential for expansion to over 500 beds.

Key highlights

Stake acquired: 5.82% of Ushahkal Abhinav Specialty Hospital LLP
Consideration: ₹15 crore in cash, by way of primary infusion
Board-approved limit: up to 6.00% stake for up to ₹15 crore
Agreements signed and consideration remitted: 29 Oct 2026
Valuation report dated 5 Oct 2026 by BDO Valuation Advisory LLP

The acquisition in numbers

Item	Detail
Target	Ushahkal Abhinav Specialty Hospital LLP, Sangli, Maharashtra
Stake acquired	5.82%
Board-approved limit	Up to 6.00%, for up to ₹15 crore
Consideration	₹15 crore, cash, by way of primary infusion
Valuation	BDO Valuation Advisory LLP report dated 5 Oct 2026
Target turnover	FY26 ₹80.42 crore, FY25 ₹73.55 crore, FY24 ₹64.51 crore
Target PAT, FY 2025-26	-₹23.59 crore
Target networth, FY 2025-26	₹116.42 crore
Beds	316 current capacity; potential for over 500

A 5.82% stake bought for cash, under a 6.00% approved ceiling

The company acquired 5.82% of the total stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 crore, by way of primary infusion. Its board had approved the purchase of up to 6.00% for an aggregate consideration of up to ₹15 crore, and the company has now entered into definitive agreements and remitted the consideration.

The company describes the stake as a strategic investment. The acquisition was based on a valuation report issued by BDO Valuation Advisory LLP, dated 5 Oct 2026.

On the same day, the company's filings also list definitive agreements for acquiring 51% stake in Sarvottam Healthcare Private Limited.

The target hospital and its numbers

The target is described as a state-of-the-art quaternary care facility founded in 2022, spanning 4 acres, and it boasts one of the highest floor-area-to-bed ratios in the region. Its current capacity is 316 beds, with potential for expansion to over 500 beds.

Its turnover was ₹64.51 crore in FY24, ₹73.55 crore in FY25 and ₹80.42 crore in FY26. For FY 2025-26 it shows a PAT of -₹23.59 crore and a networth of ₹116.42 crore.

What the stake means for Krishna Institute of Medical Sciences shareholders

The company has put ₹15 crore of cash into a 5.82% stake in a hospital LLP whose FY 2025-26 PAT is -₹23.59 crore. Not stated: the effect on the company's results, whether it will take up the rest of the 6.00% approved limit, who the other partners in the LLP are, and the timeline for completion.

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.